NasdaqCM - Delayed Quote USD
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.20
-0.30
(-4.00%)
At close: 4:00:00 PM EDT
7.20
0.00
(0.00%)
After hours: 4:20:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 122,800 | 3 |
| Sales | 16,319 | 3 |
| Net Shares Purchased (Sold) | 106,481 | 6 |
| Total Insider Shares Held | 61.77k | -- |
| % Net Shares Purchased (Sold) | -238.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SMETHURST DOMINIC Officer | Sale at price 6.78 per share. | Direct | 43,330 | Mar 6, 2025 |
| MORAN SEAN F Chief Financial Officer | Sale at price 8.76 per share. | Direct | 24,446 | Feb 14, 2025 |
| COHEN YUVAL Chief Executive Officer | Sale at price 8.76 per share. | Direct | 62,465 | Feb 14, 2025 |
| MORAN SEAN F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| COHEN YUVAL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| SMETHURST DOMINIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.48 - 22.23 per share. | Indirect | 7,003,761 | Sep 20, 2024 |
| KUNG WINSTON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 16, 2024 |
| MORAN SEAN F Chief Financial Officer | Sale at price 42.12 - 49.87 per share. | Direct | 863,838 | Jun 18, 2024 |
| COHEN YUVAL Chief Executive Officer | Sale at price 42.24 - 50.17 per share. | Direct | 2,950,518 | Jun 18, 2024 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 4.26 - 30.00 per share. | Direct | 233,820 | Jun 18, 2024 |
| COHEN YUVAL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.26 - 30.00 per share. | Direct | 962,887 | Jun 18, 2024 |
| HOLMER ALAN F Director | Conversion of Exercise of derivative security at price 30.00 per share. | Direct | 50,010 | Jun 14, 2024 |
| CATLIN AVERY W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| HOLMER ALAN F Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| JENKINS JOHN KENNETH M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| JACQUES RACHELLE SUZANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| SALZMANN PETER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| ALTMEYER ANNE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| BEN YONG Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 30, 2024 |
| MORAN SEAN F Chief Financial Officer | Conversion of Exercise of derivative security at price 30.00 per share. | Direct | 53,610 | Apr 10, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 37.82 - 45.96 per share. | Indirect | 23,327,560 | Mar 8, 2024 |
| SMETHURST DOMINIC Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2024 |
| MORAN SEAN F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| COHEN YUVAL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 12, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 26.72 per share. | Indirect | 20,040,000 | Feb 2, 2024 |
| HOLMER ALAN F Director | Conversion of Exercise of derivative security at price 4.97 per share. | Direct | 3,126 | Jan 26, 2024 |
| COHEN YUVAL Chief Executive Officer | Conversion of Exercise of derivative security at price 4.97 per share. | Direct | 35,680 | Jan 26, 2024 |
| CORMORANT ASSET MANAGEMENT ,L.P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 25.73 - 34.62 per share. | Indirect | 8,412,311 | Jan 26, 2024 |
Related Tickers
JANX Janux Therapeutics, Inc.
32.55
+0.99%
RGNX REGENXBIO Inc.
9.41
+3.07%
TIL Instil Bio, Inc.
11.72
-5.79%
RPTX Repare Therapeutics Inc.
1.3200
-2.94%
ATXS Astria Therapeutics, Inc.
5.12
+3.23%
GPCR Structure Therapeutics Inc.
25.91
+9.70%
VERV Verve Therapeutics, Inc.
5.46
-4.71%
JAGX Jaguar Health, Inc.
11.99
+12.37%
VYNE VYNE Therapeutics Inc.
1.4100
-2.08%
CRDF Cardiff Oncology, Inc.
2.7800
-5.76%